The June 14 issue of Chemical & Engineering News highlights the work of Ben Shen, professor of Pharmaceutical Sciences, and members of the Shen research team. The research concerns potent antitumor agents known as enediynes, and new understandings regarding enediyne biosynthetic divergence.